We are live on ! Find out more
HLVX

HilleVax
HLVX

Delisted

HLVX was delisted on the 16th of September, 2025.

Back to rankings

54 hedge funds and large institutions have $437M invested in HilleVax in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

222% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 9

0% more capital invested

Capital invested by funds: $436M → $437M (+$400K)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

2.47% less ownership

Funds ownership: 67.28% → 64.81% (-2.5%)

11% less funds holding

Funds holding: 61 → 54 (-7)

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
54
Holders Change
-7
Holders Change %
-11.48%
% of All Funds
0.85%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
5
Increased
29
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$7.68M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$6.39M
3
BlackRock
BlackRock
New York
+$3.61M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$3.31M
5
Deutsche Bank
Deutsche Bank
Germany
+$1.52M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$29.1M
2
PA
Perceptive Advisors
New York
-$6.71M
3
B
Braidwell
Connecticut
-$5.75M
4
BI
BVF Inc
California
-$4.11M
5
HF
HRT Financial
New York
-$297K
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$168M – – –
DM
2
Deerfield Management
New York
$57.2M +$7.68M +495,541 +17%
CG
3
Carlyle Group
District of Columbia
$31.5M – – –
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$24.5M +$3.31M +213,443 +18%
Franklin Resources
5
Franklin Resources
California
$22.1M – – –
BlackRock
6
BlackRock
New York
$21.8M +$3.61M +232,625 +22%
B
7
Braidwell
Connecticut
$21.5M -$5.75M -370,970 -23%
Vanguard Group
8
Vanguard Group
Pennsylvania
$15.5M +$6.39M +412,033 +84%
SG
9
StepStone Group
California
$11.6M – – –
SB
10
Samsara BioCapital
California
$10.3M -$164K -10,588 -2%
Morgan Stanley
11
Morgan Stanley
New York
$10.2M -$51.8K -3,344 -0.6%
QUSVM
12
Qiming U.S. Ventures Management
Washington
$9.61M – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$6.14M +$1.09M +70,046 +24%
State Street
14
State Street
Massachusetts
$6.08M +$1.25M +80,711 +30%
Northern Trust
15
Northern Trust
Illinois
$2.77M +$436K +28,116 +21%
Ensign Peak Advisors
16
Ensign Peak Advisors
Utah
$2.02M – – –
Charles Schwab
17
Charles Schwab
California
$1.93M +$144K +9,299 +9%
Deutsche Bank
18
Deutsche Bank
Germany
$1.87M +$1.52M +98,198 +911%
FAM
19
Fred Alger Management
New York
$1.5M – – –
UOC
20
UBS O'Connor
Illinois
$1.38M -$12.2K -789 -1%
ACP
21
Acuta Capital Partners
California
$1.08M +$874K +56,414 +847%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.07M +$223K +14,378 +30%
N
23
Nuveen
North Carolina
$687K +$249K +16,066 +67%
Goldman Sachs
24
Goldman Sachs
New York
$530K +$246K +15,853 +106%
AA
25
ALPS Advisors
Colorado
$495K +$106K +6,839 +31%
1
2 3

HLVX Hedge Fund Activity: Q2 2023 in Review

54 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q2 2023, worth a combined $437M — up 0.09% from $436M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of HLVX and 5 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 29 added.

The largest buyer was Deerfield Management, adding an estimated $7.68M. The largest seller was RA Capital Management, exiting entirely with an estimated $29.1M sold.

  • 54 institutional investors held HilleVax (HLVX) as of Q2 2023, down from 61 in Q1 2023.
  • Funds reported $437M of HilleVax stock for Q2 2023, up 0.09% quarter-over-quarter.
  • 5 funds opened new HilleVax positions in Q2 2023 and 11 closed out, a net change of -6 holders.
  • The largest HilleVax buyer in Q2 2023 was Deerfield Management, an estimated $7.68M added.
  • The largest HilleVax seller in Q2 2023 was RA Capital Management, an estimated $29.1M sold.

Based on aggregated 13F filings for Q2 2023.